Detalles de la búsqueda
1.
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Int J Clin Oncol
; 29(2): 96-102, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183554
2.
The efficacy and safety of anamorelin among patients with diabetes.
Int J Clin Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722487
3.
Attenuation of LPS-Induced Lung Injury by Benziodarone via Reactive Oxygen Species Reduction.
Int J Mol Sci
; 24(12)2023 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373184
4.
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
BMC Cancer
; 22(1): 323, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337281
5.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
BMC Cancer
; 22(1): 1047, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203123
6.
Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report.
BMC Pulm Med
; 20(1): 259, 2020 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023548
7.
Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.
Respir Res
; 20(1): 287, 2019 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31852459
8.
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
Thorac Cancer
; 15(6): 477-485, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243641
9.
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051.
Sci Rep
; 14(1): 3816, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360906
10.
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
JTO Clin Res Rep
; 5(1): 100613, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229769
11.
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
Thorac Cancer
; 14(5): 442-449, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36523162
12.
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
Cancers (Basel)
; 15(4)2023 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831513
13.
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
J Cachexia Sarcopenia Muscle
; 14(3): 1274-1285, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905129
14.
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
Eur J Cancer
; 184: 62-72, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905770
15.
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancer.
Thorac Cancer
; 14(35): 3475-3482, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873674
16.
Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis.
JTO Clin Res Rep
; 3(4): 100309, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35434666
17.
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection.
Thorac Cancer
; 13(18): 2654-2658, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903864
18.
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Lung Cancer
; 172: 1-8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952438
19.
Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutation.
Thorac Cancer
; 12(3): 329-338, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219754
20.
Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
Thorac Cancer
; 12(22): 3076-3079, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617405